Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Bally's (BALY) over the last 8 years, with Q3 2025 value amounting to $50.7 million.

  • Bally's' Capital Expenditures fell 4504.42% to $50.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.2 million, marking a year-over-year decrease of 1346.3%. This contributed to the annual value of $199.8 million for FY2024, which is 3584.66% down from last year.
  • Latest data reveals that Bally's reported Capital Expenditures of $50.7 million as of Q3 2025, which was down 4504.42% from $49.0 million recorded in Q2 2025.
  • In the past 5 years, Bally's' Capital Expenditures registered a high of $146.7 million during Q3 2023, and its lowest value of $15.3 million during Q1 2021.
  • Over the past 5 years, Bally's' median Capital Expenditures value was $44.9 million (recorded in 2022), while the average stood at $50.1 million.
  • As far as peak fluctuations go, Bally's' Capital Expenditures soared by 90618.99% in 2021, and later plummeted by 5293.27% in 2024.
  • Quarter analysis of 5 years shows Bally's' Capital Expenditures stood at $30.4 million in 2021, then surged by 47.83% to $44.9 million in 2022, then rose by 0.8% to $45.3 million in 2023, then dropped by 2.61% to $44.1 million in 2024, then increased by 15.12% to $50.7 million in 2025.
  • Its Capital Expenditures was $50.7 million in Q3 2025, compared to $49.0 million in Q2 2025 and $30.5 million in Q1 2025.